About this Research Topic
Many studies investigated the in-silico prediction of variants in African genomes and propose recommendations for re-evaluating the pathogenicity of actionable variants used in research and clinical practice and the actionable pathogenic variants in European and African descent using exome data. Their results showed major disparities in Africans. Some studies reported on patients that were misdiagnosed with some diseases due to a lack of access to patients in the study population from different or unspecified ancestry. This leads to misclassifications of many variants as pathogenic.
This raises two important questions to be considered in an ethnic context:
1. How could we assess the pathogenicity of a genetic variant and classify it in public databases as either pathogenic or benign?
2. What is the impact of genetic diversity on variant classification and its clinical relevance?
We believe that these questions can be addressed by investigating the variant frequency in diverse populations of different ethnicity and through well-designed studies of ethnically diverse populations to identify genetic risk factors for monogenic and polygenic diseases and the clinical relevance for diagnosis and/or therapeutic intervention plans.
Based on this, we would like to suggest this topic: “From ethnic diversity to variant actionability” and ask contributors mainly from underrepresented populations to share the topic-related results of their studies in order to bring new insights on the impact of ethnic-based genetic diversity on the clinical relevance of genetic variations.
Keywords: Diversity, Africa, NGS, Genetic Diversity, Variant actionability
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.